Hjem › Tyktarmskræft › Maryland
Tyktarmskræft kliniske forsøg i Maryland
22 studier for Tyktarmskræft søger deltagere på steder i Maryland.
Byer i Maryland
Officiel studietekst (engelsk)
Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays
- Christiana Care - Union Hospital, Elkton
RekruttererFrivillige med god helbredstilstand velkomne
Alder 18 og opefter · Alle køn · Opdateret 2. okt. 2026 · NCT07283939Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including Mesothelioma
- National Institutes of Health Clinical Center, Bethesda
RekruttererFase 1
Alder 18 til 120 · Alle køn · Opdateret 2. okt. 2026 · NCT06885697Family Communications After Genetic Testing
- Sinai Hospital of Baltimore, Baltimore
- Northwest Hospital Center, Randallstown
- UM Saint Joseph Medical Center, Towson
- og 1 flere
RekruttererFrivillige med god helbredstilstand velkomne
Alder 18 og opefter · Alle køn · Opdateret 2. okt. 2026 · NCT07143487A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)
- University of Maryland ( Site 2016), Baltimore
- Greater Baltimore Medical Center ( Site 0068), Baltimore
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 1. okt. 2026 · NCT06997497Collection of Blood From Patients With Cancer
- National Institutes of Health Clinical Center, Bethesda
RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne
Alder 18 og opefter · Alle køn · Opdateret 28. sep. 2026 · NCT00034216Genomic Services Research Program
- National Institutes of Health Clinical Center, Bethesda
RekruttererObservationsstudie
1 Month – 105 Years · Alle køn · Opdateret 28. sep. 2026 · NCT02595957Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
- Greater Baltimore Medical Center, Baltimore
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 28. sep. 2026 · NCT07222800A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
- Saint Agnes Hospital, Baltimore
- Cancer Center For Blood Disorders A Division of American Oncology Partners P.A, Bethesda
- Sarah Cannon Research Institute Scri Oncology Partners, Brandywine
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 15. sep. 2026 · NCT07284849A Phase II Platform Study to Evaluate Treatment With Cemiplimab Monotherapy or Cemiplimab Plus Fianlimab or Other Novel Combinations in Patients With Colorectal Cancer With Minimal Residual Disease Following Definitive Surgery and Chemotherapy (EMPIRE)
- University of Maryland Greenbaum, Baltimore
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 3. sep. 2026 · NCT07058012Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
- Kaiser Permanente-Woodlawn Medical Center, Baltimore
- Kaiser Permanente-Gaithersburg Medical Center, Gaithersburg
- Kaiser Permanente - Kensington Medical Center, Kensington
- og 2 flere
Rekrutterer
Alder 45 til 70 · Alle køn · Opdateret 2. sep. 2026 · NCT05080673Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
- UM Upper Chesapeake Hematology and Oncology - Aberdeen, Aberdeen
- Greater Baltimore Medical Center, Baltimore
- Sinai Hospital of Baltimore, Baltimore
- og 14 flere
RekruttererFase 2/3
Alder 18 og opefter · Alle køn · Opdateret 2. sep. 2026 · NCT05174169Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients
- National Institutes of Health Clinical Center, Bethesda
RekruttererFase 1/2
Alder 18 til 72 · Alle køn · Opdateret 24. aug. 2026 · NCT03190941KRAS-Targeted Vaccine Combined With Balstilimab and Botensilimab for Patients With Stage IV MMR-p Colorectal Cancer and Pancreatic Ductal Cancer
- Sidney Kimmel Comprehensive Cancer Center, Baltimore
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 31. jul. 2026 · NCT06411691EXoPERT EMERALD Clinical Study
- John Hopkins University, Baltimore
RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne
Alder 45 og opefter · Alle køn · Opdateret 1. jul. 2026 · NCT07186296Integrated Cancer Repository for Cancer Research
- Northwest Hospital, Randallstown
- William E. Kahlert Regional Cancer Center, Westminster
RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne
Alder 19 til 110 · Alle køn · Opdateret 29. jun. 2026 · NCT02012699A Study of Fruquintinib Plus FOLFIRI as Second-Line Treatment for Participants With Metastatic Colorectal Cancer (FRUITFUL)
- Maryland Oncology Hematology, Columbia
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 12. jun. 2026 · NCT07011576Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors
- Advanced Molecular Imaging and Therapy, Glen Burnie
- United Theranostics - Chesapeake, Glen Burnie
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 11. jun. 2026 · NCT05283330Follow-Up Study of Subjects Previously Enrolled in Poxviral Vector Gene Transfer Studies
- National Institutes of Health Clinical Center, Bethesda
RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne
Alder 18 og opefter · Alle køn · Opdateret 5. jun. 2026 · NCT00451022Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
- Johns Hopkins University, Baltimore
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 3. jun. 2026 · NCT06040541Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
- Johns Hopkins University, Baltimore
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 15. maj 2026 · NCT05379985Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer
- GSK Investigational Site, Bethesda
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 23. jan. 2026 · NCT05855200SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Baltimore
- Massive Bio SYNERGY-AI site, Bethesda
- Massive Bio SYNERGY-AI site, Silver Spring
- og 1 flere
RekruttererObservationsstudie
Alle aldre · Alle køn · Opdateret 28. okt. 2025 · NCT03452774Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.